First Choice Neurology

FDA Approves Leqembi, a New Alzheimer’s Drug

The FDA approved the new Alzheimer’s drug lecanemab (BAN2401), which will be sold under the brand name Leqembi developed by Eisai and Biogen last week for patients with mild cognitive impairment or early Alzheimer’s dementia. Leqembi was approved under the FDA’s accelerated review process, an expedited pathway that speeds access to a drug based on …

FDA Approves Leqembi, a New Alzheimer’s Drug Read More »

First Choice Neurology to Offer New Alzheimer’s Risk Test

First Choice Neurology (FCN), the largest neurology group in the U.S. with more than 41 facilities in six Florida counties and services at 35 major hospitals, has become the first neurology network in the United States to offer patients, ages 18-80, a simple saliva test to determine future risk of Alzheimer’s. The Alzheimer’s Risk Test …

First Choice Neurology to Offer New Alzheimer’s Risk Test Read More »

Research Study Shows New Alzheimer’s Drug Slows Cognitive Decline

A late-stage clinical trial was conducted by Biogen and Eisai and the new Alzheimer’s drug they are developing for Alzheimer’s disease slowed the rate of cognitive decline. New Alzheimer’s Drug – Lecanemab The results were strong, and this could offer hope for a new Alzheimer’s drug. The results were strong for the new medication, lecanemab. …

Research Study Shows New Alzheimer’s Drug Slows Cognitive Decline Read More »

Brain Fog: Cognitive Dysfunction Some Experience with Covid-19

If you’re feeling forgetful, easily distracted, or overwhelmed by mundane tasks, you may be experiencing a common phenomenon known as brain fog. It has become associated with the cognitive impairment many people experience with Covid-19. Approximately 20 to 30 percent of Covid patients have some brain fog that persists or develops after their infection, and …

Brain Fog: Cognitive Dysfunction Some Experience with Covid-19 Read More »

National Stroke Awareness Month

May is National Stroke Awareness Month and American Stroke Month. Every 40 seconds someone in the United States has a stroke, according to the American Heart Association. Stroke is the 5th leading cause of death, but you can control several risk factors for stroke. It is important to know that stroke is 80% preventable. Are …

National Stroke Awareness Month Read More »

Dr. Antonio Mesa Implements the Vertiflex Procedure for Lumbar Spinal Stenosis

Are you suffering from Lumbar Spinal Stenosis (LSS)? Do simple activities such as walking or standing become burdensome? Patients have found relief from the revolutionary, minimally invasive Vertiflex procedure performed by Dr. Antonio Mesa. The Vertiflex Procedure is clinically proven to provide effective long-term relief from the pain associated with LSS. The procedure is backed …

Dr. Antonio Mesa Implements the Vertiflex Procedure for Lumbar Spinal Stenosis Read More »

Translate »